Validation of an inductively coupled plasma-mass spectrometry method to quantify tungsten in human plasma. Determination of percentage binding to plasma proteins

Clinica Chimica Acta

Volumn 327, Issue 1-2, 2003, Pages 39-46

  Le Lamer Déchamps, Sophie ^a   Poucheret, Patrick ^a   Pérez, Jean Louis ^b   Bressolle, Françoise ^a  

^a UNIV MONTPELLIER   (France)

^b Dir Gen Concur Cons/Rep Fraud   (France)

Author keywords

Human plasma; Inductively coupled plasma mass spectrometry method; Method validation; Protein binding; Sodium tungstate

Indexed keywords

PLASMA PROTEIN; SODIUM TUNGSTATE(VI); TUNGSTEN; TUNGSTEN DERIVATIVE;

ACCURACY; ARTICLE; ASSAY; CALIBRATION; CONTROLLED STUDY; FRACTIONATION; HUMAN; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN BINDING; SIGNAL DETECTION; STATISTICAL ANALYSIS; ULTRAFILTRATION; VALIDATION PROCESS; BLOOD; METABOLISM; METHODOLOGY; PHARMACOKINETICS; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; STANDARD; VALIDATION STUDY;

BLOOD PROTEINS; CALIBRATION; HUMANS; MASS SPECTROMETRY; PHARMACOKINETICS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TUNGSTEN; TUNGSTEN COMPOUNDS; ULTRAFILTRATION;

EID: 1842856224     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(02)00331-5     Document Type: Article

References (15)

1. Barbera A., Rodriguez-Gil J.E., Guinovart J.J. Insulin-like actions of tungstate in diabetic rats. Normalization of hepatic glucose metabolism. J. Biol. Chem. 269:1994;20047-20053.
2. Barbera A., Fernandez-Alvarez J., Truc A., Gomis R., Guinovart J.J. Effects of tungstate in neonatally streptozotocin-induced diabetic rats: mechanism leading to normalization of glycaemia. Diabetologia. 40:1997;143-149.
3. Barbera A., Gomis R.R., Prats N.et al. Tungstate is an effective antidiabetic agent in streptozotocin-induced diabetic rats: a long-term study. Diabetologia. 44:2001;507-513.
4. Rodríguez-Gallardo J., Silvestre A.R., Egodo E.M., Marco J. Effects of sodium tungstate on insulin and glucagons secretion in the perfused rat pancreas. Eur. J. Pharmacol. 402:2000;199-204.
5. Le Lamer S., Poucheret P., Cros G., Kiesgen de Richter R., Bonnet P.A., Bressolle F. Pharmacokinetics of sodium tungstate in rat and dog: a population approach. J. Pharmacol. Exp. Ther. 294:2000;74-80.
6. Le Lamer S., Cros G., Piñol C., Fernández-Alvarez J., Bressolle F. An application of population kinetics analysis to estimate pharmacokinetic parameters of sodium tungstate after multiple-dose during preclinical studies in rats. Pharmacol. Toxicol. 90:2002;100-105.
7. Le Lamer S., Cros G., Serrano J.J., Piñol C., Fernández-Alvarez J., Bressolle F. Estimation of pharmacokinetic parameters of sodium tungstate after multiple-dose during preclinical studies in beagle dog. Eur. J. Pharm. Sci. 14:2001;323-329.
8. Marquet P., François B., Lotfi H.et al. Tungsten determination in biological fluids, hair and nails by plasma emission spectrometry in a case of severe acute intoxication in man. J. Forensic Sci. 42:1997;527-530.
9. Schramel P., Wendler I., Angerer J. The determination of metals (antimony, bismuth, lead, cadmium, mercury, palladium, platinum, tellurium, thallium, tin and tungsten) in urine samples by inductively coupled plasma-mass spectrometry. Int. Arch. Occup. Environ. Health. 69:1997;219-223.
10. Poucheret P., Le Lamer S., Cros G., Bonnet P.A., Bressolle F. Tungsten determination in rat and dog plasma samples by inductively coupled plasma emission spectrometry. Application to preclinical pharmacokinetic studies. Anal. Chim. Acta. 405:2000;221-226.
11. The United States Pharmacopeial Convention Inc., 12601 Twinbrook Parkway Rockville, MD 20852. 1994;1929.
12. Shah V.P., Midha K.K., Dighe S.et al. Analytical methods validation: bioavailability, bioequivalence, and pharmacokinetic studies. J. Pharm. Sci. 81:1992;309-312.
13. Bressolle F., Bromet-Petit M., Audran M. Validation of liquid chromatographic and gas chromatographic methods. Applications in pharmacokinetics. J. Chromatogr. B. 686:1996;3-10.
14. http://www.fda.gov/cder/guidance/index.htm. Guidance for Industry. Bioanalytical Method Validation. May 2001.
15. Gammelgaard B., Jons O. Determination of selenium in urine by inductively coupled plasma mass spectrometry: interferences and optimization. J. Anal. At. Spectrom. 14:1999;867-874.